文献速递腹部介入CTMR

DEB-TACE一线治疗后首次CT/MRI评估:LI-RADS疗效算法的可重复性与预后价值

LI-RADS treatment response algorithm after first-line DEB-TACE: reproducibility and prognostic value at initial post-treatment CT/MRI.
PubMed 文献 · Abdom Radiol (NY) · 2021-03-23

回顾性纳入82例HCC患者共113个靶病灶,评估一线DEB-TACE后首次CT/MRI上LR-TR与mRECIST的读者间一致性及对总生存的预后关联。LR-TR与mRECIST-overall读者间一致性为中等(κ 0.42–0.57),mRECIST-target为较明显(κ 0.62–0.66);LR-TR与mRECIST-target反应均与总生存无显著关联(P>0.05),而mRECIST-overall由全部读者和资深读者评估时与总生存显著相关(P=0.02和P=0.03),资浅读者评估时无显著关联(P=0.35)。

要点

  • 首次治疗后CT/MRI上LR-TR读者间一致性为中等,报告时应注明评估者经验。
  • LR-TR与mRECIST-target反应均未显示与总生存显著关联,不宜单独作为预后判断依据。
  • mRECIST-overall由全部读者和资深读者评估时与总生存显著相关,资浅读者评估时无显著关联。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the inter-reader reproducibility and prognostic accuracy of the Liver Imaging Reporting and Data System (LI-RADS) treatment response algorithm (LR-TR) at the time of initial post-treatment evaluation following drug-eluting beads transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma (HCC).

METHODS: This retrospective study included patients with HCC who underwent first-line DEB-TACE between January 2011 and December 2015. Six readers (three fellowship-trained radiologists and three radiology trainees) independently assessed lesion-level response in up to two treated lesions per LR-TR and modified Response Evaluation Criteria in Solid Tumors (mRECIST)-target criteria, as well as patient-level response per mRECIST-overall criteria, on the initial post-treatment CT/MRI. Inter-reader agreement was calculated by Fleiss' multi-reader κ. We tested whether LR-TR, mRECIST-target, and mRECIST-overall response were associated with overall survival using Kaplan-Meier and Cox proportional hazard model analyses.

RESULTS: A total of 82 patients with 113 treated target lesions were included. Inter-reader agreement was moderate for LR-TR and mRECIST-overall (κ range 0.42-0.57), and substantial for mRECIST-target (κ range 0.62-0.66), among all three reader-groups: all readers, experienced readers, and less-experienced readers. LR-TR and mRECIST-target response were not significantly associated with overall survival regardless of reader experience (P > 0.05). In contrast, mRECIST-overall response was significantly associated with overall survival when assessed by all readers (P = 0.02) and experienced readers (P = 0.03), but not by the less-experienced readers (P = 0.35).

CONCLUSION: Although LR-TR algorithm has moderate inter-reader reproducibility, it alone may not predict overall survival on the initial post-treatment CT/MRI after first-line DEB-TACE for HCC.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Pirasteh A, Sorra EA, Marquez H, et al. LI-RADS treatment response algorithm after first-line DEB-TACE: reproducibility and prognostic value at initial post-treatment CT/MRI. Abdom Radiol (NY). 2021. PMID: 33755735. doi:10.1007/s00261-021-03043-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。